Authors
Loading...
Requires further validation before clinical consideration; leaves open the therapeutic relevance of promoter activation mechanisms in heart disease.
Key points are not available for this paper at this time.
Biesiada et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: